ConductScience.org, home

Paper23946292

Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.

Liu Y and 6 others. Am J Physiol Renal Physiol, 2013. Cited by 31 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice. Papers, record 23946292. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23946292

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.
PubMed
Journal
Am J Physiol Renal Physiol
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2022-02-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YYing
2Jia ZZhanjun
3Liu SShanshan
4Downton MMaicy
5Liu GGang
6Du YYaomin
7Yang TTianxin

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin II Type 1 Receptor BlockersMajor topic
Diabetic NephropathiesMajor topic
LosartanMajor topic
Oleic AcidMajor topic
Albuminuria
Animals
Diabetes Mellitus, Experimental
Disease Models, Animal
Drug Therapy, Combination
Humans
Mice
Mice, Inbred C57BL
Renin-Angiotensin System

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DK-079162NIDDK NIH HHSUnited StatesR01DK079162PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in24049149Nitro-oleic acid is a novel anti-oxidative therapy for diabetic kidney disease.https://conductscience.org/library/papers/24049149

Source PubMed

Download CSV of comments and corrections

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112379575Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.Circulation2002https://conductscience.org/library/papers/12379575PubMed
218220690Role of inflammation in diabetic nephropathy.Curr Diabetes Rev2008https://conductscience.org/library/papers/18220690PubMed
315701701Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15701701PubMed
420671947Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats.PPAR Res2010https://conductscience.org/library/papers/20671947PubMed
522969168Inflammation in diabetic nephropathy.Mediators Inflamm2012https://conductscience.org/library/papers/22969168PubMed
69683226Pathogenesis, prevention, and treatment of diabetic nephropathy.Lancet1998https://conductscience.org/library/papers/9683226PubMed
716336586Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.Kidney Int Suppl2005https://conductscience.org/library/papers/16336586PubMed
817928826Renoprotective role of the vitamin D receptor in diabetic nephropathy.Kidney Int2008https://conductscience.org/library/papers/17928826PubMed
910561134End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.Am J Kidney Dis1999https://conductscience.org/library/papers/10561134PubMed
1017468336Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway.Am J Physiol Heart Circ Physiol2007https://conductscience.org/library/papers/17468336PubMed
1112660331Amelioration of diabetic nephropathy in SPARC-null mice.J Am Soc Nephrol2003https://conductscience.org/library/papers/12660331PubMed
1218753300Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury.Am J Physiol Renal Physiol2008https://conductscience.org/library/papers/18753300PubMed
1310440132
Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.
Diabetologia1999https://conductscience.org/library/papers/10440132PubMed
1412874441Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats.J Am Soc Nephrol2003https://conductscience.org/library/papers/12874441PubMed
1520182412Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.Kidney Int2010https://conductscience.org/library/papers/20182412PubMed
1620630933Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.Am J Physiol Renal Physiol2010https://conductscience.org/library/papers/20630933PubMed
1719570878Heme oxygenase: the key to renal function regulation.Am J Physiol Renal Physiol2009https://conductscience.org/library/papers/19570878PubMed
1817679649Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress.Hypertension2007https://conductscience.org/library/papers/17679649PubMed
1910652037Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.Kidney Int2000https://conductscience.org/library/papers/10652037PubMed
2011565517Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.N Engl J Med2001https://conductscience.org/library/papers/11565517PubMed

See all 48 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
41416442Advances regarding the mechanism of endoplasmic reticulum stress in diabetic kidney disease and pharmacological interventions (Review).Mol Med Rep2026https://conductscience.org/library/papers/41416442PubMed
40067577Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice.Inflammation2025https://conductscience.org/library/papers/40067577PubMed
39554401Exploring Hypertension: The Role of AT1 Receptors, Sartans, and Lipid Bilayers.ACS Omega2024https://conductscience.org/library/papers/39554401PubMed
38879114Adipocyte-specific Nrf2 deletion negates nitro-oleic acid benefits on glucose tolerance in diet-induced obesity.Nitric Oxide2024https://conductscience.org/library/papers/38879114PubMed
38179301Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/38179301PubMed
34445757Nitro-Oleic Acid (NO2-OA) Improves Systolic Function in Dilated Cardiomyopathy by Attenuating Myocardial Fibrosis.Int J Mol Sci2021https://conductscience.org/library/papers/34445757PubMed
33838229Olive oil-derived nitro-fatty acids: protection of mitochondrial function in non-alcoholic fatty liver disease.J Nutr Biochem2021https://conductscience.org/library/papers/33838229PubMed
32671602Suppression of Vascular Macrophage Activation by Nitro-Oleic Acid and its Implication for Abdominal Aortic Aneurysm Therapy.Cardiovasc Drugs Ther2021https://conductscience.org/library/papers/32671602PubMed
31196614Nitro-Fatty Acid Logistics: Formation, Biodistribution, Signaling, and Pharmacology.Trends Endocrinol Metab2019https://conductscience.org/library/papers/31196614PubMed
30769284Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis.Redox Biol2019https://conductscience.org/library/papers/30769284PubMed
29760648Profile of Arachidonic Acid-Derived Inflammatory Markers and Its Modulation by Nitro-Oleic Acid in an Inherited Model of Amyotrophic Lateral Sclerosis.Front Mol Neurosci2018https://conductscience.org/library/papers/29760648PubMed
29605557Nitrolipids in kidney physiology and disease.Nitric Oxide2018https://conductscience.org/library/papers/29605557PubMed
29578057Inflammatory signaling and metabolic regulation by nitro-fatty acids.Nitric Oxide2018https://conductscience.org/library/papers/29578057PubMed
28146117Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin.Int J Mol Sci2017https://conductscience.org/library/papers/28146117PubMed
28054588Evaluation of 10-Nitro Oleic Acid Bio-Elimination in Rats and Humans.Sci Rep2017https://conductscience.org/library/papers/28054588PubMed
26719362Protection of nitro-fatty acid against kidney diseases.Am J Physiol Renal Physiol2016https://conductscience.org/library/papers/26719362PubMed
26709810Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms.Front Biosci (Landmark Ed)2016https://conductscience.org/library/papers/26709810PubMed
26319242PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.J Am Soc Nephrol2016https://conductscience.org/library/papers/26319242PubMed
26027855Nitric oxide in liver diseases.Trends Pharmacol Sci2015https://conductscience.org/library/papers/26027855PubMed
25861250Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice.PPAR Res2015https://conductscience.org/library/papers/25861250PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23946292

GET https://conductscience.org/api/papers/v1/23946292/references?page=2